Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial
Karim Fizazi, Ken Herrmann, Bernd J. Krause, Kambiz Rahbar, Kim N. Chi, Michael J. Morris, Oliver Sartor, Scott T. Tagawa, Ayse T. Kendi, Nicholas Vogelzang, Jeremie Calais, James Nagarajah, Xiao X. Wei, Vadim S. Koshkin, Jean Mathieu Beauregard, Brian Chang, Ray Ghouse, Michelle DeSilvio, Richard A. Messmann, Johann de Bono
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial'. Together they form a unique fingerprint.